Klaus Geißler

9.4k total citations
277 papers, 6.0k citations indexed

About

Klaus Geißler is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Klaus Geißler has authored 277 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Hematology, 78 papers in Genetics and 53 papers in Immunology. Recurrent topics in Klaus Geißler's work include Acute Myeloid Leukemia Research (87 papers), Hematopoietic Stem Cell Transplantation (40 papers) and Chronic Myeloid Leukemia Treatments (36 papers). Klaus Geißler is often cited by papers focused on Acute Myeloid Leukemia Research (87 papers), Hematopoietic Stem Cell Transplantation (40 papers) and Chronic Myeloid Leukemia Treatments (36 papers). Klaus Geißler collaborates with scholars based in Austria, Germany and United States. Klaus Geißler's co-authors include Klaus Lechner, Peter Valent, Peter Bettelheim, Wolfgang R. Sperr, W Hinterberger, Ulrich Jäger, Christian Sillaber, Leopold Oehler, Hermine Agis and Eva Kabrna and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Klaus Geißler

259 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus Geißler Austria 41 2.6k 1.7k 1.4k 1.3k 1.2k 277 6.0k
Aaron Polliack Israel 43 1.4k 0.5× 1.9k 1.1× 1.5k 1.1× 1.8k 1.4× 2.2k 1.9× 375 7.7k
Shinji Nakao Japan 49 3.7k 1.4× 3.0k 1.8× 1.4k 1.0× 1.5k 1.2× 1.2k 1.0× 443 8.4k
Barbara J. Bain United Kingdom 41 3.1k 1.2× 1.2k 0.7× 879 0.6× 620 0.5× 2.2k 1.9× 390 7.1k
Ellinor I.B. Peerschke United States 46 2.6k 1.0× 2.6k 1.5× 1.5k 1.1× 536 0.4× 1.2k 1.0× 170 7.6k
Shinichiro Okamoto Japan 41 3.3k 1.3× 1.1k 0.6× 1.1k 0.8× 1.5k 1.2× 1.3k 1.1× 389 7.1k
W. Wilmanns Germany 34 1.8k 0.7× 1.4k 0.8× 1.3k 0.9× 1.2k 1.0× 556 0.5× 265 5.0k
Rajesh Chopra United Kingdom 48 3.2k 1.2× 1.7k 1.0× 2.6k 1.9× 2.8k 2.2× 1.6k 1.3× 171 8.9k
C. Erik Hack Netherlands 45 1.5k 0.6× 2.8k 1.6× 1.9k 1.4× 655 0.5× 539 0.5× 93 7.6k
C. Erik Hack Netherlands 43 1.8k 0.7× 1.8k 1.1× 1.2k 0.9× 383 0.3× 1.1k 1.0× 131 7.0k
Jaap Jan Boelens Netherlands 49 3.0k 1.2× 1.9k 1.1× 1.2k 0.9× 1.4k 1.1× 759 0.7× 276 7.3k

Countries citing papers authored by Klaus Geißler

Since Specialization
Citations

This map shows the geographic impact of Klaus Geißler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Geißler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Geißler more than expected).

Fields of papers citing papers by Klaus Geißler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Geißler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Geißler. The network helps show where Klaus Geißler may publish in the future.

Co-authorship network of co-authors of Klaus Geißler

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Geißler. A scholar is included among the top collaborators of Klaus Geißler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Geißler. Klaus Geißler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrara, Felicetto, Klaus Geißler, Priyanka Mehta, Pau Montesinos, & Adriano Venditti. (2025). Unmet needs in patients with acute myeloid leukemia ineligible for intensive approaches: perspectives from a European expert panel. Frontiers in Oncology. 15. 1642472–1642472.
2.
Geißler, Klaus, Zdeněk Kořı́stek, Teresa Bernal, et al.. (2024). Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study. British Journal of Haematology. 205(5). 1734–1745. 8 indexed citations
3.
Gao, Xin, Xiaona You, Nathalie Droin, et al.. (2022). Role of ASXL1 in hematopoiesis and myeloid diseases. Experimental Hematology. 115. 14–19. 15 indexed citations
4.
Wijsenbeek, Marlies, María Molina‐Molina, Olivier Chassany, et al.. (2022). Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures. ERJ Open Research. 8(2). 681–2021. 10 indexed citations
5.
Heibl, Sonja, Bettina Gisslinger, Peter Bettelheim, et al.. (2020). Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype. Cancers. 12(7). 1891–1891. 4 indexed citations
6.
Kerschbaumer, Andreas, Josef S Smolen, Peter Nash, et al.. (2020). Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research. RMD Open. 6(3). e001374–e001374. 44 indexed citations
7.
Polke, Markus, D Kirsten, Birgit Teucher, et al.. (2020). A Comparison of Existing Questionnaires for Identifying the Causes of Interstitial and Rare Lung Diseases. Respiration. 99(2). 119–124. 9 indexed citations
8.
Geißler, Klaus, Matthias Gunzer, & Helmut Ostermann. (2018). How Safe Is the Administration of Long-Acting Granulocyte Colony-Stimulating Factor in Cancer Patients?. Oncology Research and Treatment. 41(5). 316–326. 7 indexed citations
9.
Bonella, Francesco, Marlies Wijsenbeek, María Molina‐Molina, et al.. (2015). European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers. European Respiratory Journal. 47(2). 597–606. 81 indexed citations
10.
Agis, Hermine, Christine Mannhalter, Wolfgang R. Sperr, et al.. (2004). Detection of Trisomy 8 in Donor-Derived Ph−Cells in a Patient with Ph+Chronic Myeloid Leukemia Successfully Treated with Imatinib (STI571) in Relapse after Allogeneic Transplantation. Leukemia & lymphoma. 45(7). 1453–1458. 6 indexed citations
11.
Thalhammer-Scherrer, Renate, Klaus Geißler, Ilse Schwarzinger, et al.. (2000). Fludarabine therapy in Waldenström's macroglobulinemia. Annals of Hematology. 79(10). 556–559. 26 indexed citations
12.
Berer, A., Johannes Stöckl, Otto Majdic, et al.. (2000). 1,25-Dihydroxyvitamin D3 inhibits dendritic cell differentiation and maturation in vitro. Experimental Hematology. 28(5). 575–583. 175 indexed citations
13.
Gisslinger, Bettina, et al.. (2000). Macrocytic anemia and thrombocytosis associated with thymoma: A case report. American Journal of Hematology. 63(1). 38–41. 4 indexed citations
14.
Oehler, Leopold, A. Berer, Felix Keil, et al.. (2000). Generation of Dendritic Cells from Human Chronic Myelomonocytic Leukemia Cells in Fetal Calf Serum-Free Medium. Leukemia & lymphoma. 38(5-6). 577–586. 9 indexed citations
15.
Mitterbauer, Margit, Gerlinde Mitterbauer, Oskar A. Haas, et al.. (1995). Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia. Annals of Hematology. 71(4). 155–160. 1 indexed citations
16.
Agis, Hermine, Martin Willheim, Wolfgang R. Sperr, et al.. (1993). Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c- kit +, CD34+, Ly-, CD14-, CD17-, colony-forming cell.. The Journal of Immunology. 151(8). 4221–4227. 106 indexed citations
17.
18.
Hinterberger-Fischer, M, W Hinterberger, Helmut Gadner, et al.. (1986). Treatment of Severe Aplastic Anemia with Combined Immunosuppression (Antithymocyte Globulin and High-Dose Methylprednisolone). Acta Haematologica. 76(4). 196–201. 10 indexed citations
19.
Thiele, Susanne, et al.. (1980). Ergebnisse vierjähriger Produktionsexperimente zur Bekämpfung der Vergilbungsviren in Zuckerrübenbeständen. 34(6). 115–118. 2 indexed citations
20.
Geißler, Klaus, et al.. (1980). Tagebücher und Reiseberichte.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aaron Polliack Breakdown of academic impact, for papers by Shinji Nakao Breakdown of academic impact, for papers by Barbara J. Bain Breakdown of academic impact, for papers by Ellinor I.B. Peerschke Breakdown of academic impact, for papers by Shinichiro Okamoto Breakdown of academic impact, for papers by W. Wilmanns Breakdown of academic impact, for papers by Rajesh Chopra Breakdown of academic impact, for papers by C. Erik Hack Breakdown of academic impact, for papers by C. Erik Hack Breakdown of academic impact, for papers by Jaap Jan Boelens
Rankless by CCL
2026